Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Researchers need your help. By taking part in research studies and clinical trials, you will help them make progress to improve lives and find a cure for type 1 diabetes.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & events > News > Update on NovoRapid PumpCart supply for YpsoPump users
There is a specific issue affecting the NovoRapid PumpCart 1.6ml cartridges, which are used in the mylife YpsoPump insulin pump. This means that while some people may be able to continue using PumpCart for now, others may be asked to switch to using NovoRapid vials with YpsoPump reservoirs, either temporarily or permanently.
If you currently use PumpCart cartridges, your diabetes team may ask you to switch to NovoRapid vials and fill YpsoPump reservoirs manually.
Your GP should now prescribe 10ml vials of NovoRapid instead of PumpCart cartridges.
If you receive your pump supplies from your hospital, they will arrange for you to receive YpsoPump reservoirs.
If you order directly from YpsoMed, we recommend placing an order for YpsoPump reservoirs now, so you have them ready when your PumpCart supply runs out.
YpsoPump reservoirs are made of glass, which means it is safe to pre-fill several in advance.
If you’ve recently switched to using vials and reservoirs, we recommend monitoring your glucose levels more closely during the transition. If you have any concerns, please speak to your diabetes team.
If you’re already using NovoRapid vials to fill your pump, this shortage will not affect you.
You can find more information about the mylife YpsoPump insulin pump reservoirs and watch a video guide on how to use them. For further support, you can contact YpsoMed by email at Info@ypsomed.co.uk or call their customer care team on 0344 856 7820.
We’ll continue to monitor the situation and share updates as they become available. Our priority is to ensure that everyone affected by type 1 diabetes has the information and support they need to manage their treatment with confidence.
Find out about the global research we're funding to find cures and better treatments for T1D.
Get information and advice about living well with type 1.
Join our mission to find cures for T1D and, until then, make life better for people living with it.
You may have heard of a new feature called ‘CamAPS Liberty’, which will soon be available on the CamAPS FX app. This ‘fully closed-loop’ (FCL) mode, when activated; will allow users to remove the need to count carbohydrates before a meal. But what does this mean for people with type 1 diabetes (T1D), and how close are we to removing meal announcement altogether? Here is what we know…
In draft guidance published today, NICE recommends that anyone with type 1 diabetes who is pregnant or planning a pregnancy should be offered pregnancy-specific HCL technology.
Discussing the main themes from this year's Advanced Technologies & Treatments for Diabetes conference – early detection, cellular cures and disease-modifying therapies.
Highlights from an extraordinary year in type 1 diabetes (T1D) research, treatment, advocacy and policy.
Immunotherapy, beta cell replacement, smart insulins – we’re driving research in the most promising areas to find cures and better treatments for type 1 diabetes.
